top of page


Sacubitril/Valsartan is well tolerated in patients with HF and renal disorders: TRANSITION Study
Patients with coexisting heart failure (HF) and renal dysfunction (RD) face a significantly poorer prognosis compared to those with HF alone, experiencing higher rates of hospitalization, mortality, and morbidity. Managing patients with heart failure with reduced ejection fraction (HFrEF) and renal dysfunction (RD) is challenging due to the risk of further worsening of kidney function, particularly following an episode of acute decompensated heart failure (ADHF). Initiating a

Ms. Reddy Francy Priyanka
Sep 9, 20253 min read
Â
Â
bottom of page